Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 March 2022 | Story Leonie Bolleurs | Photo Supplied
Dr Edson Vengeai
Dr Edson Vengesai believes accreditation from and affiliation with the CFA Institute signals to potential students, employers, and the marketplace that the UFS BCom Investment Management and Banking curriculum is well-suited to prepare students for a brighter career in the investment field.

The University of the Free State (UFS) Faculty of Economic and Management Sciences was recently welcomed into the world’s largest association of investment professionals, the CFA Institute University Affiliation Programme. The CFA designation is globally recognised as the gold standard in the investment field.

Accreditation by this respected source of knowledge in investment and portfolio management reflects the rigour and value of the UFS BCom Investment Management and Banking (IMB) degree – housed in the more than a century-old Department of Economics and Finance. 

According to Dr Edson Vengesai, Senior Lecturer in the Department of Economics and Finance, the BCom IMB positions students well to obtain the Chartered Financial Analyst (CFA®) charter, which has become the world's most respected and recognised investment credential. Including the UFS, only five universities in South Africa are affiliated to the CFA Institute. 

Most respected investment designation

Members who have attained the prestigious designation ‘Chartered Financial Analyst’, hold prominent roles in leading investment firms in financial centres worldwide. “Becoming a charter holder is a defining moment for many investment professionals, which exemplifies a robust understanding of advanced investment analysis and real-world portfolio management skills,” he says.  

Dr Vengesai states that with this affiliation from the CFA Institute, the BCom IMB degree has been acknowledged as incorporating at least 70% of the CFA Program Candidate Body of Knowledge (CBOK) within the programme. Moreover, it also places emphasis on the CFA Institute Code of Ethics and Standards of Professional Conduct. He believes preparing graduates who are ethically grounded and ready to execute their duties in an ethical and professional manner is a major necessity in the financial analysis and investment field.

Writing from London in the United Kingdom, Director of University Relations at the CFA Institute, Peter Watkins, states: “The UFS BCom in Investment Management and Banking is a rigorous programme that will be of great benefit to students entering the investment profession.”

Dean of the Faculty of Economic and Management Sciences and Pro-Vice-Chancellor: Poverty, Inequality and Economic Development, Prof Philippe Burger, adds that the accreditation aligns with the faculty’s drive to create opportunities for its students to not only pursue excellence, but also to compare with the best in the industry, locally and on an international basis. He says the BCom in Investment Management and Banking is one of a range of cutting-edge, industry-relevant, and scientifically rigorous degrees offered by the Faculty of Economic and Management Sciences. “Quite a number of the faculty’s programmes are accredited by professional bodies, with accreditation by the CFA being the latest.”

Taking the financial sector to new heights

Through the CFA programme, the UFS will also be eligible to receive CFA Programme Student Scholarships each year, which will contribute to the much-needed skill set of well-grounded financial analysts who can take the financial sector to new heights. “Aligning our degree programme with the CFA curriculum will equip our students with the kind of expertise and real-world skills in investment analysis that will help set them apart from other institutions and peers,” adds Dr Vengesai, who also aims to produce a breed of innovators, critical thinkers, and producers of information.

“The affiliation signals to potential students, employers, and the marketplace that the UFS BCom Investment Management and Banking curriculum is closely tied to professional practices and is well-suited to prepare students for a brighter career in the investment field,” Dr Vengesai concludes. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept